U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07340320) titled 'A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus' on Jan. 13.
Brief Summary: This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good blood sugar control while taking a steady dose of metformin, with or without a steady dose of an SGLT2 inhibitor, for at least 90 days.
The study is being done at multiple medical centers. Participants are assigned by chance (randomized) to different groups, and neither the participants nor the study staff know which group they're in (double-blind). The groups are compared side by side (parallel), and...